Interestingly, activated platelets, known to destabilize pCRP to the pro-inflammatory pCRP*/mCRP isoforms, have been identified as an early marker of primary tumors and metastases (78), indicating that CRP activation at the site of cancerous tissue contributes to a pro-inflammatory state in cancer patients. This evidence concerns the gene CRP and cancer.